Moncton, N.B.-headquartered Organigram (Organigram Stock Quote, Chart, News, Analysts, Financials TSX:OGI) reported first-quarter fiscal 2026 results that came in below expectations, but Haywood Securities analyst Neal Gilmer says the company’s strengthened balance sheet and strategic backing support a constructive outlook. In a Feb. 10 note, Gilmer said he recommends buying the shares at current levels, […]
Beacon Securities analyst Russell Stanley maintained a “Buy” rating and C$5.00 price target on Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart, News, Analysts, Financials TSX:CURA) after the company announced what he described as a landmark refinancing for the U.S. cannabis sector. In a Feb. 9 note, Stanley said Curaleaf has secured commitments for a US$500-million […]
Share
Tweet
Share
